First Time Loading...

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 0.105 AUD 5% Market Closed
Updated: May 31, 2024

PYC Therapeutics Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PYC Therapeutics Ltd
PP&E Net Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
PYC Therapeutics Ltd
ASX:PYC
PP&E Net
AU$1.2m
CAGR 3-Years
4%
CAGR 5-Years
48%
CAGR 10-Years
15%
Immutep Ltd
ASX:IMM
PP&E Net
AU$795.5k
CAGR 3-Years
34%
CAGR 5-Years
84%
CAGR 10-Years
0%
Mesoblast Ltd
ASX:MSB
PP&E Net
$5.5m
CAGR 3-Years
-19%
CAGR 5-Years
45%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
PP&E Net
$9.6B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
19%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
PP&E Net
AU$7.9m
CAGR 3-Years
39%
CAGR 5-Years
89%
CAGR 10-Years
51%
Telix Pharmaceuticals Ltd
ASX:TLX
PP&E Net
AU$30.5m
CAGR 3-Years
85%
CAGR 5-Years
167%
CAGR 10-Years
N/A

See Also

What is PYC Therapeutics Ltd's PP&E Net?
PP&E Net
1.2m AUD

Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's PP&E Net amounts to 1.2m AUD.

What is PYC Therapeutics Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
15%

Over the last year, the PP&E Net growth was -3%. The average annual PP&E Net growth rates for PYC Therapeutics Ltd have been 4% over the past three years , 48% over the past five years , and 15% over the past ten years .